The plasma levels of PLA2G7, UBR5, APOE, MMP9, STAT5B, and S100A8 emerge as pivotal biomarkers for predicting the evolution from normal cognition to MCI and further degradation to AD. The gene discussed is MMP9; the disease is Alzheimer disease.